| Date |
Title |
Category |
|
| 19/01/2010 | Alcon plans to purchase Sirion Therapeutics assets | Pharmaceutical Company Restructures | Read More |
| 18/01/2010 | £309,461.91 sold for £5,000 | Pharmaceutical Company Restructures | Read More |
| 18/01/2010 | PharmaSmart 'went into administration in 2009' | Pharmaceutical Company Restructures | Read More |
| 12/01/2010 | Cephalon reveals executive vice-president position | Pharmaceutical Company Restructures | Read More |
| 11/01/2010 | Biogen Idec announces appointment of new executive vice-president | Pharmaceutical Company Restructures | Read More |
| 08/01/2010 | Daiichi Sankyo subsidiary acquires PharmaForce | Pharmaceutical Company Restructures | Read More |
| 07/01/2010 | ABPI welcomes DoH generic substitution consultation | Pharmaceutical Company Restructures | Read More |
| 06/01/2010 | Sanofi-aventis to purchase Chattem | Pharmaceutical Company Restructures | Read More |
| 06/01/2010 | Shire announces Dr Michael Rosenblatt has stepped down | Pharmaceutical Company Restructures | Read More |
| 05/01/2010 | Lilly ensures business support provision with new appointment | Pharmaceutical Company Restructures | Read More |
| 05/01/2010 | Alcon independent director committee issues Novartis response | Pharmaceutical Company Restructures | Read More |
| 05/01/2010 | Merck Sharp & Dohme to acquire Avecia biologics business | Pharmaceutical Company Restructures | Read More |
| 04/01/2010 | Merck Sharpe and Dohme announces new head of vaccines division | Pharmaceutical Company Restructures | Read More |
| 04/01/2010 | Novartis to acquire majority share of Alcon | Pharmaceutical Company Restructures | Read More |
